Ironwood Pharmaceuticals Financial Ratios
NASDAQ: IRWDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.82-0.05 (-1.29%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ironwood Pharmaceuticals ratio analysis
Ironwood Pharmaceuticals earned a net margin of 8.1% in FY 2025, up from 0.3% a year earlier. At the end of FY 2025, IRWD traded at 28.5 times earnings; across the 6 fiscal years shown, its year-end P/E ranged from 3.6 to 451.0, with a median of 22.9. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Ironwood Pharmaceuticals financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 28.47 | 451.00 | — | 12.91 | 3.63 | 17.26 | 94.14 | — | — | — |
| Price / sales | 2.33 | 2.04 | 4.02 | 4.66 | 4.57 | 4.66 | 4.80 | 4.06 | 6.27 | 6.77 |
| Price / book | — | — | — | 2.93 | 3.12 | 28.99 | — | — | 189.94 | 27.82 |
| Gross margin | — | — | — | — | — | 99.2% | 94.4% | 90.6% | 93.6% | 99.3% |
| Operating margin | 33.3% | 26.5% | -213.5% | 61.0% | 56.1% | 36.7% | 28.0% | -43.5% | -5.2% | -18.9% |
| Net margin | 8.1% | 0.3% | -226.4% | 42.6% | 127.7% | 27.3% | 5.0% | -81.5% | -39.2% | -29.8% |
| Free cash flow margin | 42.9% | 29.4% | 41.4% | 66.6% | 63.2% | 42.9% | 0.8% | -20.5% | -34.7% | -11.0% |
| Return on equity (ROE) | — | — | — | 26.8% | 87.2% | 169.5% | — | — | -1,187.4% | -122.5% |
| Return on assets (ROA) | 6.1% | 0.3% | -212.8% | 15.9% | 46.9% | 19.0% | 5.3% | -85.0% | -19.3% | -11.5% |
| Debt / equity | — | — | — | 0.61 | 0.75 | 6.87 | — | — | 14.92 | 1.98 |
| Current ratio | 1.13 | 4.69 | 0.84 | 30.58 | 4.61 | 15.41 | 7.50 | 2.23 | 4.72 | 4.17 |
| Revenue growth | -15.7% | -20.6% | 7.8% | -0.8% | 6.2% | -9.1% | 23.6% | 16.2% | 8.9% | 83.2% |
| EPS growth | 1,400.0% | — | -771.9% | -70.1% | 386.4% | 371.4% | — | — | — | — |